Abstract
People with type 2 diabetes are often prescribed multiple medicines which can be difficult to manage. Nonadherence to medicines can be intentional (e.g. active decision) or unintentional (e.g. forgetting). The objective of this study was to measure intentional and unintentional non-adherence to differing numbers of medicines prescribed in type 2 diabetes. A cross-sectional survey using the Morisky medication adherence scale (with intentional and unintentional non-adherence subscales) was completed by 480 people prescribed oral antidiabetic drugs (OADs), antihypertensive agents and statins. A within-subject analysis of variance (ANOVA) showed that intentional non-adherence did not vary between OADs, anti-hypertensives and statins. Intentional non-adherence to statins significantly increased when the number of medicines prescribed was included as a between-subjects variable (p
Original language | English |
---|---|
Pages (from-to) | 148-152 |
Number of pages | 4 |
Journal | British Journal of Diabetes and Vascular Disease |
Volume | 10 |
Issue number | 3 |
DOIs | |
Publication status | Published - May 2010 |
Keywords
- Adherence
- Co-morbid
- Compliance
- Decisionmaking
- Polypharmacy